Skip to main content

Advertisement

SpringerLink
Log in

Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of α-difluoromethylornithine (DFMO) in breast cancer cells

  • Preclinical Study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

We have shown that administration of α-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (ODC), the first and rate-limiting enzyme in polyamine (PA) biosynthesis, reduces the invasive and metastatic properties of MDA-MB−435 breast cancer cells while activating multiple signal transduction pathways, including MAPK, Stat3, Stat1, and JNK. Since the activity of these signaling mechanisms is frequently regulated by upstream tyrosine kinases (TKs), we tested whether non-receptor and receptor TKs may be involved in the signaling and biological effects of DFMO in MDA-MB−435 cells. Treatment with DFMO (1 mM for 48 h) did not affect Src phosphorylation (Tyr 416). Administration of the Src-family members inhibitor PP-1 (1 μM), blocked Src phosphorylation in the absence and in the presence of DFMO, but did not block the signaling effects of DFMO (increased phosphorylation of Stat3, Stat1, ERK and JNK). PP-1 treatment, on the other hand, inhibited the invasiveness of MDA-MB−435 cells in matrigel and potentiated the anti-invasive effect of DFMO. Next, we focused on the role of receptor TK. Western analysis of cell lysates from MDA-MB−435 cells failed to show the presence of EGF-R and HER-2neu but demonstrated the expression of c-Met, the receptor for hepatocyte growth factor (HGF). Therefore, we tested the effect of DFMO on the HGF/c-Met pathway which is strongly implicated in the progression of human breast cancer. We found that DFMO treatment blocked HGF-induced c-Met phosphorylation in MDA-MB−435 cells, suggesting that its anti-invasion action may be mediated, at least in part, by blocking c-Met signaling. Next, we showed that 1 mM DFMO suppressed HGF induced invasiveness of MDA-MB−435 cells in matrigel. Combination administration of DFMO with suboptimal doses of PHA-665752, a specific c-Met inhibitor, reduced invasiveness to an even greater extent than the individual treatment. These findings indicate that Src-family members, while not involved in DFMO action, promote invasiveness of breast cancer cells and their inhibition may enhance the antitumor effect of PA depletion. Our data also point to inhibition of HGF/c-Met pathway as a possible novel approach to enhancing the antitumor action of DFMO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Manni A, Grove R, Kunselman S et al (1995) Involvement of the polyamine pathway in breast cancer progression. Cancer Lett 92:49–57

    Article  PubMed  CAS  Google Scholar 

  2. Manni A, Badger B, Martel J et al (1992) Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice. Cancer Lett 66:1–9

    Article  PubMed  CAS  Google Scholar 

  3. Glikman P, Manni A, Demers L et al (1989) Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture. Cancer Res 49:1371–1376

    PubMed  CAS  Google Scholar 

  4. Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48:759–774

    PubMed  CAS  Google Scholar 

  5. Poulin R, Pelletier G, Pegg AE (1995) Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem J 311:723–727

    PubMed  CAS  Google Scholar 

  6. Pegg AE (2006) Regulation of ornithine decarboxylase. J Biol Chem 281:14529–14532

    Article  PubMed  CAS  Google Scholar 

  7. Sunkara PS, Rosenberger AL (1987) Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Cancer Res 47:933–935

    PubMed  CAS  Google Scholar 

  8. Takahashi Y, Mai M, Nishioka K (2000) Alpha-difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int J Cancer 85:243–247

    PubMed  CAS  Google Scholar 

  9. Manni A, Washington S, Craig L et al (2003) Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. Clin Exp Metastasis 20:321–325

    Article  PubMed  CAS  Google Scholar 

  10. Manni A, Washington S, Griffith JW et al (2002) Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells. Clin Exp Metastasis 19:95–105

    Article  PubMed  CAS  Google Scholar 

  11. Hu X, Washington S, Verderame MF et al (2005) Interaction between polyamines and the mitogen-activated protein kinase pathway in the regulation of cell cycle variables in breast cancer cells. Cancer Res 65:11026–11033

    Article  PubMed  CAS  Google Scholar 

  12. Hu X, Washington S, Verderame MF et al (2004) Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo. Int J Oncol 25:1831–1838

    PubMed  CAS  Google Scholar 

  13. Ray RM, Zimmerman BJ, McCormack SA et al (1999) Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. Am J Physiol 276:C684–C691

    PubMed  CAS  Google Scholar 

  14. Chen Y, Alm K, Vujcic S et al (2003) The role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells. Cancer Res 63:3619–3625

    PubMed  CAS  Google Scholar 

  15. Pfeffer LM, Yang CH, Pfeffer SR et al (2000) Inhibition of ornithine decarboxylase induces STAT3 tyrosine phosphorylation and DNA binding in IEC-6 cells. Am J Physiol Cell Physiol 278:C331–C335

    PubMed  CAS  Google Scholar 

  16. Manni A, Trout D, Verderame MF et al (2001) Effect of alpha-difluoromethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture. Breast Cancer Res Treat 68:139–146

    Article  PubMed  CAS  Google Scholar 

  17. Garcia R, Bowman TL, Niu G et al (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20:2499–2513

    Article  PubMed  CAS  Google Scholar 

  18. Garcia R, Yu CL, Hudnall A et al (1997) Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 8:1267–1276

    PubMed  CAS  Google Scholar 

  19. Silva CM (2004) Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23:8017–8023

    Article  PubMed  CAS  Google Scholar 

  20. Diaz N, Minton S, Cox C et al (2006) Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clin Cancer Res 12:20–28

    Article  PubMed  CAS  Google Scholar 

  21. Anagnostopoulou A, Vultur A, Arulanandam R et al (2006) Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Cancer Lett 242:120–132

    Article  PubMed  CAS  Google Scholar 

  22. Cooper CS (1992) The met oncogene: from detection by transfection to transmembrane receptor for hepatocyte growth factor. Oncogene 7:3–7

    PubMed  CAS  Google Scholar 

  23. Yamashita J, Ogawa M, Yamashita S et al (1994) Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54:1630–1633

    PubMed  CAS  Google Scholar 

  24. Yamashita J, Ogawa M, Beppu T (1993) Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines. Res Commun Chem Pathol Pharmacol 82:249–252

    PubMed  CAS  Google Scholar 

  25. Ronen D, Altstock RT, Firon M et al (1999) Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells. Cell Growth Differ 10:131–140

    PubMed  CAS  Google Scholar 

  26. Manni A, Washington S, Mauger D et al (2004) Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO) in human breast cancer cells. Clin Exp Metastasis 21:461–467

    Article  PubMed  CAS  Google Scholar 

  27. Hanke JH, Gardner JP, Dow RL et al (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271:695–701

    Article  PubMed  CAS  Google Scholar 

  28. Christensen JG, Schreck R, Burrows J et al (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res 63:7345–7355

    PubMed  CAS  Google Scholar 

  29. Smolen GA, Sordella R, Muir B et al (2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci USA 103:2316–2321

    Article  PubMed  CAS  Google Scholar 

  30. O’Shaughnessy JA, Demers LM, Jones SE et al (1999) Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients. Clin Cancer Res 5:3438–3444

    PubMed  CAS  Google Scholar 

  31. Richert MM, Phadke PA, Matters G et al (2005) Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. Breast Cancer Res 7:R819–827

    Article  PubMed  CAS  Google Scholar 

  32. Matters GL, Manni A, Bond JS (2005) Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells. Clin Exp Metastasis 22:331–339

    Article  PubMed  CAS  Google Scholar 

  33. Wilson GR, Cramer A, Welman A et al (2006) Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer 95:1410–1414

    Article  PubMed  CAS  Google Scholar 

  34. Verbeek BS, Vroom TM, Adriaansen-Slot SS et al (1996) c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180:383–388

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

Grant support: National Cancer Institute Grant RO1 CA98237-01A1.

Author information

Authors and Affiliations

  1. Department of Medicine, The Pennsylvania State University College of Medicine, Hershey, PA, USA

    Haifang Xu, Sharlene Washington, Michael F. Verderame & Andrea Manni

  2. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA, 17033, USA

    Andrea Manni

Authors
  1. Haifang Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharlene Washington
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael F. Verderame
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Manni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Manni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xu, H., Washington, S., Verderame, M.F. et al. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of α-difluoromethylornithine (DFMO) in breast cancer cells. Breast Cancer Res Treat 112, 255–261 (2008). https://doi.org/10.1007/s10549-007-9866-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-007-9866-3

Keywords

Search

Navigation